Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2471-2480 of 2870 for cancer

Edit search filters
  1. A Study For Germline Mutations Of Patients With Phyllodes Tumors Of The Breast

    Rochester, MN

  2. Establishment Of Preclinical Models From Patients With Gynecological Malignancies

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. A Study of Pharmacogenomics Results and Clinical Data of Patients with Chronic Myeloid Leukemia and Lung Cancer to Assess Current and Future Therapeutic Relevance

    Rochester, MN

  4. Evaluation Of A Patient-Reported Symptom Index For NMIBC

    Rochester, MN

  5. A Study to Compare Optimal MRI Timing for Pre-surgical Planning to LINAC-based Therapy

    Rochester, MN

  6. Olmsted County Healthy Skin Study

    Rochester, MN

  7. Reporting Of Side Effects Among Stage III And IV Melanoma Patients Treated With Immune Checkpoint Inhibitors

    Rochester, MN

  8. Breast Imaging with Positron Emission Mammography

    Rochester, MN

  9. Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection

    Rochester, MN

  10. Study Of Validated Biomarkers In Urine For Patients With Adenocarcinoma Of The Prostate

    Rochester, MN

.

Mayo Clinic Footer